• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胸壁肿块的发生率及治疗结果:一份10年报告。

Frequency and treatment outcomes of chest wall masses: a 10-year report.

作者信息

Rezaei Reza, Amir Fakhrian Seyed Hamed, Mehri Ali, Fattahi Masoum Seyed Hossein

机构信息

Endoscopic and Minimally Invasive Surgery Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

Department of General Surgery, Zahedan University of Medical Sciences, Mashhad, Iran.

出版信息

Kardiochir Torakochirurgia Pol. 2024 Dec;21(4):223-228. doi: 10.5114/kitp.2024.145848. Epub 2024 Dec 12.

DOI:10.5114/kitp.2024.145848
PMID:39781434
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11704756/
Abstract

INTRODUCTION

Chest wall tumors, though rare, represent a significant subset of thoracic neoplasms, accounting for approximately 5% of thoracic and 2% of overall body neoplasms. Their management has historically posed challenges for surgeons, often leading to misdiagnosis, incomplete resection, and high complication rates. An individualized surgical approach, tailored to the specific characteristics of the disease, is crucial for optimizing outcomes.

AIM

To evaluate the outcomes of chest wall masses and report on individual cases.

MATERIAL AND METHODS

This retrospective cohort study included 131 patients diagnosed with chest wall masses at Ghaem University Hospital between 2011 and 2021. Data on demographics (age, gender), pre- and post-operative pathology, specific surgical procedures performed, duration of hospitalization, need for post-surgical reconstruction (e.g., flap reconstruction), and history of pre-operative chemotherapy/radiotherapy were collected from medical records. Data were analyzed using descriptive statistics and appropriate inferential tests depending on the variable type. Potential limitations such as missing data or selection bias were acknowledged.

RESULTS

A total of 131 patient records were examined, with an average age of 17.35 ±38.51 years. Of these, 50 (38.2%) were female and 81 (61.8%) were male. It was found that 54.2% of patients had benign tumors, while 45.8% had malignant tumors. Sarcoma (26%) and fibromatosis (21.4%) were the most common tumor types. No significant associations were observed between gender or history of chemotherapy and radiotherapy and the type of surgery performed ( > 0.05). However, a significant association was found between tumor histology and the type of surgery performed ( < 0.05).

CONCLUSIONS

The majority of procedures performed were for fibromatous and benign tumors, while the most common malignant tumors were sarcomas, with chondrosarcoma being the predominant subtype. Tumor type significantly influenced the extent of resection and need for chest wall reconstruction.

摘要

引言

胸壁肿瘤虽然罕见,但却是胸部肿瘤的一个重要子集,约占胸部肿瘤的5%,占全身肿瘤的2%。其治疗在历史上一直给外科医生带来挑战,常常导致误诊、切除不完全和高并发症发生率。针对疾病的特定特征采取个性化的手术方法对于优化治疗效果至关重要。

目的

评估胸壁肿块的治疗效果并报告个别病例。

材料与方法

这项回顾性队列研究纳入了2011年至2021年间在加姆大学医院被诊断为胸壁肿块的131例患者。从病历中收集了人口统计学数据(年龄、性别)、术前和术后病理、所进行的具体手术程序、住院时间、术后重建需求(如皮瓣重建)以及术前化疗/放疗史。根据变量类型,使用描述性统计和适当的推断性检验对数据进行分析。承认了数据缺失或选择偏倚等潜在局限性。

结果

共检查了131份患者记录,平均年龄为17.35±38.51岁。其中,50例(38.2%)为女性,81例(61.8%)为男性。发现54.2%的患者患有良性肿瘤,而45.8%患有恶性肿瘤。肉瘤(26%)和纤维瘤病(21.4%)是最常见的肿瘤类型。在性别或化疗和放疗史与所进行的手术类型之间未观察到显著关联(>0.05)。然而,在肿瘤组织学与所进行的手术类型之间发现了显著关联(<0.05)。

结论

所进行的大多数手术是针对纤维瘤性和良性肿瘤,而最常见的恶性肿瘤是肉瘤,其中软骨肉瘤是主要亚型。肿瘤类型显著影响切除范围和胸壁重建需求。

相似文献

1
Frequency and treatment outcomes of chest wall masses: a 10-year report.胸壁肿块的发生率及治疗结果:一份10年报告。
Kardiochir Torakochirurgia Pol. 2024 Dec;21(4):223-228. doi: 10.5114/kitp.2024.145848. Epub 2024 Dec 12.
2
Massive chest wall resection and reconstruction for malignant disease.针对恶性疾病的大面积胸壁切除与重建术。
Onco Targets Ther. 2016 Apr 19;9:2349-58. doi: 10.2147/OTT.S101615. eCollection 2016.
3
Management of Malignant Chest Wall Tumors.恶性胸腔壁肿瘤的治疗管理。
J Coll Physicians Surg Pak. 2021 Jul;31(7):833-836. doi: 10.29271/jcpsp.2021.07.833.
4
The surgical management of sarcomas of the chest wall: A 13-year single institution experience.胸壁肉瘤的外科治疗:单机构 13 年经验。
J Plast Reconstr Aesthet Surg. 2020 Aug;73(8):1448-1455. doi: 10.1016/j.bjps.2020.02.036. Epub 2020 Mar 4.
5
Primary chest wall sarcoma: advances in surgical management and outcomes.原发性胸壁肉瘤:手术治疗及预后进展
Eur J Orthop Surg Traumatol. 2025 Apr 1;35(1):141. doi: 10.1007/s00590-025-04260-1.
6
Primary chest wall sarcoma; a single institution experience of 3 years.原发性胸壁肉瘤;单机构 3 年经验。
Cancer Treat Res Commun. 2021;27:100326. doi: 10.1016/j.ctarc.2021.100326. Epub 2021 Jan 27.
7
11-year experience with Chest Wall resection and reconstruction for primary Chest Wall sarcomas.对原发性胸壁肉瘤进行胸壁切除及重建的11年经验。
J Cardiothorac Surg. 2020 Jan 28;15(1):29. doi: 10.1186/s13019-020-1064-y.
8
Complications of chest wall around malignant tumors: differences based on reconstruction strategy.恶性肿瘤周围胸壁并发症:基于重建策略的差异。
BMC Cancer. 2024 Aug 6;24(1):964. doi: 10.1186/s12885-024-12690-z.
9
Mini review: surgical management of primary chest wall tumors.综述:原发性胸壁肿瘤的外科治疗
Gen Thorac Cardiovasc Surg. 2016 Dec;64(12):707-714. doi: 10.1007/s11748-016-0719-z. Epub 2016 Oct 24.
10
Histopathological features of chest wall masses: a systematic review.胸壁肿块的组织病理学特征:一项系统综述
Ann Med Surg (Lond). 2025 Mar 7;87(5):2889-2895. doi: 10.1097/MS9.0000000000003125. eCollection 2025 May.

本文引用的文献

1
Chest-Wall Tumors and Surgical Techniques: State-of-the-Art and Our Institutional Experience.胸壁肿瘤与手术技术:最新进展及我们机构的经验
J Clin Med. 2022 Sep 20;11(19):5516. doi: 10.3390/jcm11195516.
2
Chest wall reconstruction with implantable cross-linked porcine dermal collagen matrix: Evaluation of clinical outcomes.使用可植入交联猪真皮胶原基质进行胸壁重建:临床结果评估
JTCVS Tech. 2022 Feb 22;13:250-260. doi: 10.1016/j.xjtc.2022.01.021. eCollection 2022 Jun.
3
Chest wall resection and reconstruction for recurrent breast cancer - A multidisciplinary approach.胸壁切除术和重建术治疗复发性乳腺癌 - 多学科方法。
Surgeon. 2020 Aug;18(4):208-213. doi: 10.1016/j.surge.2019.10.001. Epub 2020 Jan 6.
4
Chest Wall Resection and Reconstruction: Management of Complications.胸壁切除与重建:并发症的处理
Thorac Surg Clin. 2015 Nov;25(4):517-21. doi: 10.1016/j.thorsurg.2015.07.013.
5
Global cancer patterns: causes and prevention.全球癌症模式:病因与预防。
Lancet. 2014 Feb 8;383(9916):549-57. doi: 10.1016/S0140-6736(13)62224-2. Epub 2013 Dec 16.
6
Chest wall resection and reconstruction according to the principles of biomimesis.根据仿生学原理进行的胸壁切除与重建。
Semin Thorac Cardiovasc Surg. 2011 Winter;23(4):307-13. doi: 10.1053/j.semtcvs.2012.01.011.
7
Review of chest wall tumors: a diagnostic, therapeutic, and reconstructive challenge.胸腔肿瘤的回顾:诊断、治疗和重建的挑战。
Semin Plast Surg. 2011 Feb;25(1):16-24. doi: 10.1055/s-0031-1275167.
8
Current strategy for triple-negative breast cancer: appropriate combination of surgery, radiation, and chemotherapy.三阴性乳腺癌的现行治疗策略:手术、放疗和化疗的适当结合。
Breast Cancer. 2011 Jul;18(3):165-73. doi: 10.1007/s12282-011-0254-9. Epub 2011 Feb 3.
9
The role of neoadjuvant chemotherapy and surgery in cervical cancer.新辅助化疗和手术在宫颈癌中的作用。
Int J Gynecol Cancer. 2010 Oct;20(11 Suppl 2):S42-6. doi: 10.1111/igc.0b013e3181f60d73.
10
Lifestyle as risk factor for cancer: Evidence from human studies.生活方式与癌症风险:来自人体研究的证据。
Cancer Lett. 2010 Jul 28;293(2):133-43. doi: 10.1016/j.canlet.2009.12.013. Epub 2010 Jan 18.